Corestreet Logo

Crispr Therapeutics AG (CRSP) Insider Trading

Total insider buys:
  • $79,647,674.22
Total insider sells:
  • $318,344,969.15
Most recent insider trade:
  • Feb. 19, 2026
Most active insider trader:
  • Samarth Kulkarni
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 19, 2026CEO6,967$52.58Sell$366,324.86
Feb. 19, 2026General Counsel2,112$52.58Sell$111,048.96
July 16, 2025Director989,812$52.03Buy$51,499,918.36
May 29, 2025Insider3,932$35.94Sell$141,316.08
March 11, 2025General Counsel2,850$42.42Sell$120,897.00
March 11, 2025CEO9,973$42.42Sell$423,054.66
March 11, 2025COO1,198$42.42Sell$50,819.16
Feb. 26, 2025Director7,000$44.85Buy$313,950.00
Feb. 19, 2025CEO18,360$55.20Sell$1,013,472.00
Dec. 2, 2024CEO15,000$55.10Sell$826,500.00
Nov. 11, 2024CEO30,000$55.62Sell$1,668,600.00
Oct. 14, 2024CEO4,293$46.28Sell$198,680.04
Oct. 14, 2024General Counsel1,089$46.28Sell$50,398.92
June 21, 2024COO3,366$56.09Sell$188,798.94
April 15, 2024CEO19,582$59.91Sell$1,173,157.62
March 15, 2024CEO20,000$72.48Sell$1,449,600.00
March 15, 2024CFO3,524$72.69Sell$256,159.56
March 11, 2024General Counsel2,801$78.26Sell$219,206.26
March 11, 2024CEO9,802$78.26Sell$767,104.52
Feb. 20, 2024CEO6,370$79.67Sell$507,497.90
Feb. 20, 2024General Counsel1,913$79.67Sell$152,408.71
Feb. 15, 2024CEO20,000$80.36Sell$1,607,200.00
Jan. 29, 2024CEO50,000$60.51Sell$3,025,500.00
Jan. 16, 2024CEO20,000$62.50Sell$1,250,000.00
May 30, 2023CEO25,000$64.88Sell$1,622,000.00
April 25, 2023CEO25,000$50.67Sell$1,266,750.00
March 29, 2023CEO25,000$44.46Sell$1,111,500.00
Feb. 27, 2023CEO25,000$48.25Sell$1,206,250.00
Jan. 27, 2023CEO25,000$51.47Sell$1,286,750.00
Dec. 28, 2022CEO25,000$40.93Sell$1,023,250.00
Nov. 28, 2022CEO25,000$54.03Sell$1,350,750.00
Oct. 26, 2022CEO25,000$54.81Sell$1,370,250.00
Sept. 28, 2022CEO25,000$64.61Sell$1,615,250.00
Aug. 29, 2022CEO25,000$66.84Sell$1,671,000.00
July 27, 2022CEO25,000$75.91Sell$1,897,750.00
June 29, 2022CEO25,000$61.59Sell$1,539,750.00
Aug. 6, 2021CFO25,000$138.52Sell$3,463,000.00
Aug. 4, 2021CEO1,500$125.02Sell$187,530.00
July 19, 2021Director10,000$126.43Sell$1,264,300.00
June 30, 2021President25,000$165.00Sell$4,125,000.00
June 28, 2021Director20,375$152.48Sell$3,106,780.00
June 21, 2021President25,000$128.62Sell$3,215,500.00
June 15, 2021CEO30,000$126.43Sell$3,792,900.00
June 11, 2021Director10,000$126.61Sell$1,266,100.00
March 22, 2021Director30,374$132.37Sell$4,020,606.38
Jan. 19, 2021General Counsel27,500$204.94Sell$5,635,850.00
Jan. 15, 2021COO25,000$215.20Sell$5,380,000.00
Jan. 15, 2021CEO20,000$213.67Sell$4,273,400.00
Dec. 21, 2020VP23,551$149.23Sell$3,514,515.73
Dec. 16, 2020Director7,648$148.95Sell$1,139,169.60
First«1 of 4»Last

  • Insiders are both buying and selling Crispr Therapeutics AG stock.

  • The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, James R Kasinger, Pablo J Cagnoni, Thomas Woiwode, Lawrence Otto Klein, Vertex Pharmaceuticals (Europe, Michael John Tomsicek, Simeon George, Julianne Bruno, Naimish Patel, Bradley J. Phd Bolzon, James R. Kasinger, John Greene, Aktiengesellschaft Bayer, Raju Prasad, Tony W Ho, Tony W. Ho, and Versant Venture Capital V, L.P

  • The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 37 trades.

  • Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.

  • Simeon George has bought the most Crispr Therapeutics AG stock with a total value of $103,930,836.72.

  • The most recent insider trade for Crispr Therapeutics AG was on Feb. 19, 2026.

  • The single biggest insider buy for Crispr Therapeutics AG was from Simeon George with a total value of $51,499,918.36 on July 16, 2025.

  • The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.